CERAMENT® BONE VOID FILLER is an injectable, moldable, drillable and radiopaque bone substitute which provides rapid and complete bone remodeling within 6-12 months. CERAMENT is an ideal bone substitute for a wide range of orthopedic applications including hip, knee and shoulder arthroplasty, traumatic fractures, benign bone tumors and cysts, arthrodesis, charcot foot and hardware removal.
Unique features of CERAMENT:
Injectable, moldable, drillable
Rapid and complete bone remodeling
Highly visible under fluoroscopy
30 second, enclosed mix
Not temperature sensitive
Robust clinical data
"OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients."
Amnio Technology, LLC is a global leader in the development and distribution of amniotic tissue allografts. Amniotic tissue contains extracellular matrix proteins, growth factors, cytokines, carbohydrates, hyaluronic acid, and other elements naturally present in amniotic fluid and tissue essential for fetal growth and development. Amnio Technology is committed to advancing the science and use of these unique allografts to improve quality of life for patients in need.Type your paragraph here.
MedShape. We are what the future feels like. As a constantly evolving orthopedic device company that utilizes proprietary advanced material technologies, we fuse brilliant design with surgical expertise. Now surgeons can use the most innovative orthopedic devices anywhere - unique devices created from our shape memory biomaterials that can transform and adapt inside the body. Together, we are dramatically improving the technology of soft tissue fixation, fracture repair, and joint fusions. That kind of change isn't just good - it's great!
Smith & Nephew supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.
They do this by taking a pioneering approach to the design of advanced medical products and services, by securing wider access to diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems.
They have leadership positions in:
-Orthopaedics Reconstruction - joint replacement systems for knees, hips and shoulders
-Trauma & Extremities - products that help repair broken bones
-Annual sales in 2015 were more than $4.6 billion.
-They are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)